Hemoccult® ICT


Hemoccult’s Newest Gold Standard in FOBTs-Hemoccult® ICT

Hemoccult ICT is the latest and most advanced FOBT in the Hemoccult family of rapid, diagnostic tests. As an immunochemical FOBT (iFOBT), Hemoccult ICT has major advantages over traditional guaiac FOBTs, which make it an ideal screening tool and a superb product for you to recommend to your physician clients1-4:




Superior specificity for lower GI disease and bleeding-makes Hemoccult ICT an ideal CRC screening tool.



Human hemoglobin specific means fewer false positives.



Increased specificity with high sensitivity.


Hemoccult ICT's clinical effectiveness has been established in clinical trials.



No diet or medication restrictions for better patient compliance and test completion.

CLIA waived

Better for Your Physician Clients
 

When physicians switch from guaiac to an immunochemical FOBT, such as Hemoccult ICT, they will be able to provide better healthcare to their patients.
   

High Sensitivity
 
The sensitivity for Hemoccult ICT was selected on the basis of a clinical research study using actual patient samples and the findings were used to establish the optimal test formulation for Hemoccult ICT.5-6
   

High Clinical Specificity
 

Hemoccult ICT’s excellent clinical specificity has been determined in a group of average risk individuals. The presence of any lower GI pathology that could be related to bleeding was determined by follow-up colonoscopy for all individuals with a positive FOBT. As an immunochemical FOBT (iFOBT), Hemoccult ICT yields inherently superior clinical specificity when compared to guaiac-based FOBTs.5-6
   

No Diet or Drug Restrictions
 


Hemoccult ICT does not require any dietary or drug restrictions on the part of patients prior to or during the test period and it can recognize small amounts of human hemoglobin as a biological indicator of gastrointestinal (GI) disease.

Hemoccult ICT Product Configurations (377k)

Hemoccult® ICT Part I (749k)

Hemoccult® ICT Part II (716k)

Hemoccult ICT Material Safety Data Sheets

Ordering Hemoccult ICT
   

References:

1. Young GP, St John DJB. Faecal occult blood tests: choice, usage and clinical applications. Clin Biochem Rev 1992; 13: 161-167.

2. Rozen P, Knaani J, Samuel Z. Comparative screening with a sensitive guaiac and specific immunochemical occult blood test in an endoscopic study. Cancer 2000; 89; 46-52.

3. Rozen P, Knaani J, Samuel Z. Performance characteristics and comparison of two immunochemical and two guaiac fecal occult blood screening tests for colorectal neoplasia. Dig Dis Sci 1997; 42(10): 2064-2071.

4. Young GP, St. John DJB. Selecting an occult blood test for use as a screening tool for large bowel cancer. Rozen P, Reich CB, Winawer SJ, (eds); Large Bowel Cancer: Policy, Prevention, research and Treatment. In Front Gastrointest Res 18; pp 135-156. Basel, Karger 1991.

5. Data on file, Beckman Coulter, Inc. 2004.

6. Hemoccult ICT Product Instructions 2005.